These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33675618)

  • 1. Outcomes After Second-Line Antiretroviral Therapy in Children Living With HIV in Latin America.
    Somerville K; Jenkins CA; Carlucci JG; Person AK; Machado DM; Luque MT; Pinto JA; Rouzier V; Friedman RK; McGowan CC; Shepherd BE; Rebeiro PF
    J Acquir Immune Defic Syndr; 2021 Jul; 87(3):993-1001. PubMed ID: 33675618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
    Cesar C; Jenkins CA; Shepherd BE; Padgett D; Mejía F; Ribeiro SR; Cortes CP; Pape JW; Madero JS; Fink V; Sued O; McGowan C; Cahn P;
    Lancet HIV; 2015 Nov; 2(11):e492-500. PubMed ID: 26520929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network.
    Wolff M; Shepherd BE; Cortés C; Rebeiro P; Cesar C; Wagner Cardoso S; Pape JW; Padgett D; Sierra-Madero J; Echevarria J; McGowan CC;
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):102-10. PubMed ID: 26761273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.
    Smiley CL; Rebeiro PF; Cesar C; Belaunzaran-Zamudio PF; Crabtree-Ramirez B; Padgett D; Gotuzzo E; Cortes CP; Pape J; Veloso VG; McGowan CC; Castilho JL;
    Lancet HIV; 2021 May; 8(5):e266-e273. PubMed ID: 33891877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America.
    Luque MT; Jenkins CA; Shepherd BE; Padgett D; Rouzier V; Succi RCM; Machado DM; McGowan CC; Vermund SH; Pinto JA
    J Pediatr; 2017 Mar; 182():245-252.e1. PubMed ID: 28081884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded access to viral load testing and use of second line regimens in Haiti: time trends from 2010-2017.
    Wang Y; Barnhart S; Francois K; Robin E; Kalou M; Perrin G; Hall L; Koama JB; Marinho E; Balan JG; Honoré JG; Puttkammer N
    BMC Infect Dis; 2020 Apr; 20(1):283. PubMed ID: 32299389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America.
    Cesar C; Koethe JR; Giganti MJ; Rebeiro P; Althoff KN; Napravnik S; Mayor A; Grinsztejn B; Wolff M; Padgett D; Sierra-Madero J; Gotuzzo E; Sterling TR; Willig J; Levison J; Kitahata M; Rodriguez-Barradas MC; Moore RD; McGowan C; Shepherd BE; Cahn P;
    J Int AIDS Soc; 2016; 19(1):20684. PubMed ID: 26996992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort.
    Carriquiry G; Giganti MJ; Castilho JL; Jayathilake K; Cahn P; Grinsztejn B; Cortes C; Pape JW; Padgett D; Sierra-Madero J; McGowan CC; Shepherd BE; Gotuzzo E
    J Int AIDS Soc; 2018 Mar; 21(3):e25088. PubMed ID: 29569354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.
    Boerma RS; Bunupuradah T; Dow D; Fokam J; Kariminia A; Lehman D; Kityo C; Musiime V; Palumbo P; Schoffelen A; Sophan S; Zanoni B; Rinke de Wit TF; Calis JCJ; Sigaloff KCE;
    J Int AIDS Soc; 2017 Sep; 20(1):21930. PubMed ID: 28953325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis.
    Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
    J Int AIDS Soc; 2020 Apr; 23(4):e25477. PubMed ID: 32297485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
    Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ
    BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
    Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study.
    Yihun BA; Kibret GD; Leshargie CT
    PLoS One; 2019; 14(5):e0215300. PubMed ID: 31042743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in Asia.
    Prasitsuebsai W; Teeraananchai S; Singtoroj T; Truong KH; Ananworanich J; Do VC; Nguyen LV; Kosalaraksa P; Kurniati N; Sudjaritruk T; Chokephaibulkit K; Kerr SJ; Sohn AH
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):380-6. PubMed ID: 27355415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
    Collier D; Iwuji C; Derache A; de Oliveira T; Okesola N; Calmy A; Dabis F; Pillay D; Gupta RK;
    Clin Infect Dis; 2017 Apr; 64(8):1006-1016. PubMed ID: 28329393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
    Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
    PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.